{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:27:13Z","timestamp":1785392833331,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109144201725"],"award-info":[{"award-number":["JCYJ20200109144201725"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220530163412028"],"award-info":[{"award-number":["JCYJ20220530163412028"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KJZD20240903101359020"],"award-info":[{"award-number":["KJZD20240903101359020"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010253"],"award-info":[{"award-number":["2023A1515010253"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.virusres.2025.199531","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:28:34Z","timestamp":1738319314000},"page":"199531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion"],"prefix":"10.1016","volume":"353","author":[{"given":"Chongwei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanghua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-1722","authenticated-orcid":false,"given":"Junfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.virusres.2025.199531_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.22076","article-title":"Cell penetrating peptides: highlighting points in cancer therapy","volume":"84","author":"Asrorov","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.virusres.2025.199531_bib0002","doi-asserted-by":"crossref","first-page":"43160","DOI":"10.1038\/srep43160","article-title":"Yield optimisation of hepatitis B virus core particles in E. coli expression system for drug delivery applications","volume":"7","author":"Bin Mohamed Suffian","year":"2017","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.virusres.2025.199531_bib0003","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.febslet.2009.08.030","article-title":"Broadly neutralizing anti-HBV antibody binds to non-epitope regions of preS1","volume":"583","author":"Chi","year":"2009","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/v14020434","article-title":"Current trend in antiviral therapy for chronic hepatitis B","volume":"14","author":"Chien","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.virusres.2025.199531_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101892","article-title":"Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: results from a 3-year survey in an Italian tertiary-care hospital","volume":"46","author":"De Conto","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.virusres.2025.199531_bib0006","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.virusres.2025.199531_bib0007","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jinf.2021.12.025","article-title":"Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: anti-HBV PreS1 antibody","volume":"84","author":"Hatooka","year":"2022","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.virusres.2025.199531_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3350\/cmh.2020.0032","article-title":"Novel biomarkers for the management of chronic hepatitis B","volume":"26","author":"Inoue","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"issue":"10381","key":"10.1016\/j.virusres.2025.199531_bib0009","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.virusres.2025.199531_bib0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3390\/cells9092023","article-title":"Intracellular trafficking of HBV particles","volume":"9","author":"Jiang","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.virusres.2025.199531_bib0011","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs: progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2025.199531_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2017.10.017","article-title":"Efficacy of NVR 3-778, alone and in combination with pegylated interferon, vs entecavir in uPA\/SCID mice with humanized livers and HBV infection","volume":"154","author":"Klumpp","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0013","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jviromet.2008.05.025","article-title":"Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein","volume":"151","author":"Lee","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2025.199531_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B virus infection: overview","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0015","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2223669","article-title":"Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus","volume":"12","author":"Li","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"6","key":"10.1016\/j.virusres.2025.199531_bib0016","first-page":"702","article-title":"Development of monoclonal antibody-based antigens detection assays for orthopoxvirus and monkeypox virus","volume":"85","author":"Li","year":"2022","journal-title":"J. Infect."},{"issue":"14","key":"10.1016\/j.virusres.2025.199531_bib0017","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/bph.13811","article-title":"Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus","volume":"174","author":"Li","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"5 Suppl","key":"10.1016\/j.virusres.2025.199531_bib0018","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virusres.2025.199531_bib0019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.virusres.2025.199531_bib0020","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/v14122654","article-title":"Gene editing technologies to target HBV cccDNA","volume":"14","author":"Martinez","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2025.199531_bib0021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.virusres.2025.199531_bib0022","doi-asserted-by":"crossref","first-page":"39774","DOI":"10.1038\/srep39774","article-title":"Determination of equilibrium dissociation constants for recombinant antibodies by high-throughput affinity electrophoresis","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2025.199531_bib0023","first-page":"348","article-title":"New direct-acting antiviral agents and immunomodulators for hepatitis B virus infection","volume":"13","author":"Peters","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.virusres.2025.199531_bib0038","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","article-title":"TRIM21 and the function of antibodies inside cells","volume":"38","author":"Rhodes","year":"2017","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2025.199531_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0168-1656(94)90153-8","article-title":"High level expression of hepatitis B virus preS1 peptide in Escherichia coli","volume":"36","author":"Rhyum","year":"1994","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.intimp.2015.01.028","article-title":"Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro","volume":"25","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.virusres.2025.199531_bib0027","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1158\/1535-7163.MCT-12-0476-T","article-title":"A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targets","volume":"11","author":"Weisbart","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017 - recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0029","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/ijmm.2012.1210","article-title":"Intracellular-delivery of a single-chain antibody against hepatitis B core protein via cell-penetrating peptide inhibits hepatitis B virus replication in vitro","volume":"31","author":"Xun","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.virusres.2025.199531_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.510300105","article-title":"Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells","volume":"30","author":"Yamamoto","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.virusres.2025.199531_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230086","article-title":"A novel nanobody broadly neutralizes SARS-CoV-2 via induction of spike trimer dimers conformation","volume":"4","author":"Yang","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.virusres.2025.199531_bib0032","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2468-1253(19)30346-2","article-title":"Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebocontrolled phase 1 trial","volume":"5","author":"Yuen","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2025.199531_bib0033","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2018.12.023","article-title":"Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection","volume":"156","author":"Yuen","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.virusres.2025.199531_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/thno.20047","article-title":"A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.virusres.2025.199531_bib0035","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.virusres.2025.199531_bib0036","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/acsinfecdis.8b00269","article-title":"Discovery of novel hepatitis B virus nucleocapsid assembly inhibitors","volume":"5","author":"Zhang","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2025.199531_bib0037","doi-asserted-by":"crossref","first-page":"415","DOI":"10.20892\/j.issn.2095-3941.2021.0454","article-title":"Research progress in hepatitis B virus covalently closed circular DNA","volume":"19","author":"Zhang","year":"2021","journal-title":"Cancer Biol. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170225000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170225000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:29:06Z","timestamp":1777508946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170225000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"alternative-id":["S0168170225000073"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2025.199531","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2025.199531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Yuebei People's Hospital. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199531"}}